Taylor & Francis Group
Browse
1/1
2 files

Exploring insecticide resistance mechanisms in three major malaria vectors from Bangui in Central African Republic

Version 2 2019-04-01, 11:30
Version 1 2018-11-15, 17:34
dataset
posted on 2019-04-01, 11:30 authored by Basile Kamgang, Williams Tchapga, Carine Ngoagouni, Claire Sangbakembi-Ngounou, Murielle Wondji, Jacob M. Riveron, Charles S. Wondji

Malaria remains the main cause of mortality and morbidity in the Central African Republic. However, the main malaria vectors remain poorly characterised, preventing the design of suitable control strategies. Here, we characterised the patterns and mechanisms of insecticide resistance in three important vectors from Bangui.

Mosquitoes were collected indoors, using electrical aspirators in July 2016 in two neighborhoods at Bangui. WHO bioassays performed, using F2 An. gambiae sensu lato (s.l.), revealed a high level of resistance to type I (permethrin) and II (deltamethrin) pyrethroids and dichlorodiphenyltrichloroethane (< 3% mortality). Molecular analysis revealed the co-occurrence of Anopheles coluzzii (56.8 %) and An. gambiae s.s. (43.2%) within the An. gambiae complex. Anopheles funestus s.s. was the sole species belonging to An. funestus group. Both kdr-w (40% of homozygotes and 60% of heterozygotes/kdr-w/wild type) and kdr-e (37.5% of heterozygotes) mutations were found in An. gambiae. Contrariwise, only the kdr-w (9.5% homozygotes and 85.7% of heterozygotes) was detected in An. coluzzii. Quantitative RT-PCR showed that CYP6M2 and CYP6P3 are not upregulated in An. coluzzii from Bangui. Analysis of the sodium channel gene revealed a reduced diversity in An. coluzzii and An. gambiae s.s. In An. funestus s.s., the pyrethroid/DDT GSTe2 L119F resistance allele was detected at high frequency (54.7%) whereas a very low frequency for Rdl was observed. Polymorphism analysis of GSTe2 and GABA receptor gene in An. funestus revealed the presence of one resistant haplotype for each gene.

This study provides baseline information to help guide current and future malaria vector control interventions in CAR.

Funding

This work was supported by the Wellcome Trust under Grant 083515/Z/07/Z to CSW and 204862/Z/16/Z to BK.

History

Usage metrics

    Pathogens and Global Health

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC